Cost Effectiveness Analysis (CEA) Strategi Terapi Anemia pada Pasien Penyakit Ginjal Kronis

Challenges on management of heart failure in Indonesia: a general practitioner’s perspective

Gagal jantung telah menjadi masalah kesehatan masyarakat karena insidensi dan prevalensi yang terus meningkat. Sebagian besar pasien dengan gagal jantung datang ke pelayanan kesehatan primer dan dikelola oleh dokter umum. Diagnosis yang akurat sangat diperlukan untuk manajemen penyakit ini. Umumnya gejala dan tanda saja tidak cukup spesifik untuk mendiagnosis penyakit gagal jantung. Beberapa st...

IFNγ modulates human immunoglobulin receptor expression in lipoaspirate-derived mesenchymal stem cells

Latar belakang: Sel punca mesenkim (MSC) mempunyai kapasitas imunomodulator terhadap penyakit autoimun dan mencegah penolakan imun alogenik. Banyak studi mengungkapkan bahwa MSC menghambat proliferasi sel T dan menginduksi kondisi imunosupresi melalui produksi prostaglandin dan interleukin-10. Pemberian MSC pada pasien autoimun dapat mengurangi autoantibodi di sirkulasi. Sejauh ini belum pernah...

cost effectiveness of anemia screening: a systematic review

background: anemia is the most common blood disorder observed in vulnerable groups and affects their efficiency in their everyday activities. possible complications of the disease may be reduced or prevented by screening of patients. screening programs impose certain costs upon the health system, which may offset their positive effects. whether the positive impacts of screening outweigh its cos...

Cost-Effectiveness Analysis

CEA is a tool that has seen increasing use in recent decades as decision makers at all levels of health care provision seek to value alternative interventions (or programs, tests, or treatments). Although CEAs can be complex, and are often described using somewhat arcane terminology, the concept at the core of any CEA is fairly simple: to combine the net cost of a given intervention and its out...

Cost-Effectiveness Analysis